United States Vaccine Market Analysis Report 2023: Market is Projected to Increase by 47% to $35.1 Billion in 2030

DUBLIN, Jan. 18, 2024 /PRNewswire/ — The “2023 U.S. Vaccine Market Report” report has been added to ResearchAndMarkets.com’s offering.

The U.S. vaccine market is valued at $23.8 billion in 2023 and is projected to increase by 47% to $35.1 billion in 2030. The growth of the vaccine market is driven largely by the commercialization of the COVID-19 vaccine and the development of new innovative vaccines.

Overall vaccination coverage among adults and children has decreased in recent years as vaccine hesitancy and fatigue have risen. The 2023 Vaccine Market Report describes the overall vaccine market, including the approval process, updated vaccination schedules, vaccines progressing through clinical trials, necessary vaccine supplies, and market value for childhood, adult, influenza, and COVID-19 vaccines.

Doses administered: Over 676 million doses of the individual COVID-19 vaccine and booster doses were administered in the U.S. by May of 2023.Vaccination rates: Adult vaccination rates in 2022 declined 14% compared to 2019.Doses manufactured: An estimated 170 million doses of the influenza vaccine will be manufactured for the 2023-2024 flu season, a 17% decrease from the prior flu season.

Key Topics Covered:

Executive SummaryVaccine Market OverviewVaccine Categories And Development PlatformsMessenger RNA Vaccines Evolve To Target Infectious Disease Prevention And Cancer TreatmentPlasmid DNA Breast Cancer Vaccine Shows Promise In Early-Phase StudiesFDA Approves First Vaccine Designed To Prevent RSV Disease In Infants, Babies, And ToddlersRoutine Childhood Vaccination Rates Remain Below Key TargetsRising Vaccine Hesitancy Is Impacting Vaccine CoverageCombined COVID-Flu Combination Vaccine No Longer Expected In 2023Updated Vaccines Are Authorized And Recommended For 2023-2024 COVID-19 SeasonGlobal COVID-19 Vaccine Market Experiences Drop In Projected SalesPharmacies Play A Key Role In COVID-19 Vaccine Administration For Adults And ChildrenCDC Adds COVID-19 Vaccine To Adult And Child Immunization SchedulesMinimal Updates To Flu Vaccine Composition Ahead Of The 2023-2024 Flu SeasonInfluenza Activity And Market Value Rise As Manufacturing FallsHigh Australian Flu Cases Precede U.S. Flu SeasonPediatric And Adolescent Vaccination Schedule GrowsHPV Vaccination Rate Among Adolescents Continues To Fall Behind Other VaccinesInitial Study Demonstrates Efficacy And Safety Of Needle-Free Measles-Rubella VaccineLimited Number Of Domestic Manufacturers Contributes To Vaccine Supply Chain DisruptionsGovernment Programs Or Insurance Cover Most Recommended VaccinesAppendices

For more information about this report visit https://www.researchandmarkets.com/r/c9r6b9

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/united-states-vaccine-market-analysis-report-2023-market-is-projected-to-increase-by-47-to-35-1-billion-in-2030–302038275.html

SOURCE Research and Markets